Male sexual dysfunction associated with TNF-α inhibitors: an indication-stratified global pharmacovigilance analysis. [PDF]
Chu Y, Luo M, Li W, Wang X, Zhou Y.
europepmc +1 more source
Tumor necrosis factor inhibitors and cardiovascular outcomes in adults with moderate-to-severe plaque psoriasis: a systematic review and meta-analysis. [PDF]
Mesa Rodríguez LF +2 more
europepmc +1 more source
A Case of Etanercept Induced Palmoplantar Pustular Psoriasis
Observations: Etanercept is a human recombinant soluble tumor necrosis factor (TNF-α) receptor fusion protein. Etanercept has been used successfully to treat a wide range of inflammatory disorders including psoriasis and psoriatic arthritis resistant to
Zennure Takçı +3 more
core
Differential Expression of Visfatin, Sirtuin-1, and Interleukin-18 in Ankylosing Spondylitis Patients: A Comparative Study of Etanercept-Treated versus Newly Diagnosed Patients. [PDF]
Asgarian A +6 more
europepmc +1 more source
Background: Tumor necrosis factor (TNF) antagonists are biologic response modifiers that have significantly improved the outcomes in patients with rheumatoid arthritis (RA).
SANGARI D +8 more
core
Impact of etanercept on the progression of undifferentiated arthritis to rheumatoid arthritis: A prospective observational study in China. [PDF]
Shen J +5 more
europepmc +1 more source
Etanercept in Steroid-Refractory Acute Graft Versus Host Disease: Clinical Response, Toxicity, and Long-Term Outcomes. [PDF]
Chichra A +13 more
europepmc +1 more source
Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. [PDF]
Vitturi G +40 more
europepmc +1 more source
Rapid Improvement in Cerebral Palsy Following Treatment With Perispinal Etanercept: A Case Report. [PDF]
Ucci D +4 more
europepmc +1 more source

